Top compounds associated with response to THSD1


Feature Type Standardized
Nominal ANOVA
mRNA HLI 373 CTRPv2 pan-cancer AAC -0.017 0.6
mRNA istradefylline CTRPv2 pan-cancer AAC 0.028 0.6
mRNA vincristine CTRPv2 pan-cancer AAC -0.015 0.7
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.024 0.7
mRNA MLN2238 CTRPv2 pan-cancer AAC 0.017 0.7
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.7
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.023 0.7
mRNA FQI-1 CTRPv2 pan-cancer AAC -0.021 0.7
mRNA PDMP CTRPv2 pan-cancer AAC -0.018 0.7
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.018 0.7
Download CSV